Tempest Therapeutics, Inc. Share Price
TPSTTempest Therapeutics, Inc. Stock Performance
Open $1.91 | Prev. Close $1.96 | Circuit Range N/A |
Day Range $1.78 - $1.91 | Year Range $1.52 - $12.06 | Volume 2,439 |
Average Traded $1.86 |
Tempest Therapeutics, Inc. Share Price Chart
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Tempest Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Apr-26 | $1.97 | $1.96 | +0.26% |
17-Apr-26 | $2.25 | $1.96 | -13.11% |
16-Apr-26 | $2.05 | $2.25 | +6.13% |
15-Apr-26 | $2.21 | $2.12 | -4.93% |
14-Apr-26 | $2.16 | $2.23 | +3.96% |
13-Apr-26 | $2.13 | $2.15 | +5.15% |
10-Apr-26 | $1.61 | $2.04 | +30.77% |
FAQs on Tempest Therapeutics, Inc. Share Price
Can I buy Tempest Therapeutics, Inc. shares in India?
What is the share price of Tempest Therapeutics, Inc.?
What is the 5 year returns of Tempest Therapeutics, Inc.?
What are the high & low stock price of Tempest Therapeutics, Inc. today?
What is the 52-week high and low of Tempest Therapeutics, Inc. stock?